Ishibashi Naoko, Park In-Sam, Takahashi Yukiko, Nishiyama Mitsunori, Murakami Yasue, Mori Katsuhiko, Mimori Shigekazu, Ando Makoto, Takahashi Yukihiro, Nakanishi Toshio
Department of Pediatrics and Cardiovascular Surgery, Sakakibara Heart Institute, Asahi-machi 3-16-1, Fuchu-shi, Tokyo, Japan.
Pediatr Cardiol. 2006 Jul-Aug;27(4):473-5. doi: 10.1007/s00246-006-1105-x. Epub 2006 Jul 13.
We report a case of a patient with severe heart failure after Fontan procedure in whom carvedilol was very effective. A 27-year-old man had intractable congestive heart failure due to severe ventricular dysfunction after Fontan operation. Central venous pressure was elevated to 29 mmHg. A right-to-left shunt was noted across a large collateral vessel between the innominate vein and the pulmonary vein. He was administered carvedilol (initial dose, 2 mg/day; maximum dose, 30 mg/day). Cardiac catheterization performed 1 year after carvedilol administration revealed a decrease in atrial pressure and improvement of ventricular function. He underwent a conversion operation to total cavopulmonary connection (TCPC) and ligation of a collateral vein communicating with the innominate and pulmonary veins. Carvedilol may be a legitimate treatment before TCPC conversion or heart transplantation for the high-risk group of patients with a failed Fontan circulation.